In addition, our results shed light on pathological mechanisms underlying retinitis pigmentosa caused by mutations in the human MAK gene and suggest that activation of Ick is a potential therapeutic approach to treat this disease. The gene discussed is CILK1; the disease is retinitis pigmentosa.